The estimated Net Worth of Holdings (Private) Ltd Temasek is at least $476 Milion dollars as of 3 November 2020. Holdings Temasek owns over 625,000 units of SQZ Biotechnologies Co stock worth over $1,120,205 and over the last 21 years Holdings sold SQZ stock worth over $475,152,000.
Sign up
Holdings Temasek SQZ stock SEC Form 4 insiders trading
Holdings has made over 9 trades of the SQZ Biotechnologies Co stock since 2003, according to the Form 4 filled with the SEC. Most recently Holdings bought 625,000 units of SQZ stock worth $10,000,000 on 3 November 2020.
The largest trade Holdings's ever made was selling 16,000,000 units of SQZ Biotechnologies Co stock on 16 January 2019 worth over $254,400,000. On average, Holdings trades about 4,813,055 units every 619 days since 2003. As of 3 November 2020 Holdings still owns at least 2,513,924 units of SQZ Biotechnologies Co stock.
You can see the complete history of Holdings Temasek stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Holdings Temasek's mailing address?
Holdings's mailing address filed with the SEC is 60B ORCHARD ROAD, #06-18 TOWER 2, THEATRIUM@ORCHARD, SINGAPORE, U0, 233891.
Insiders trading at SQZ Biotechnologies Co
Over the last 4 years, insiders at SQZ Biotechnologies Co have traded over $3,939 worth of SQZ Biotechnologies Co stock and bought 2,233,026 units worth $35,530,795 . The most active insiders traders include Holdings (Private) Ltd Temasek, Public Equities, L.P.Minne ... oraz Amy W Schulman. On average, SQZ Biotechnologies Co executives and independent directors trade stock every 50 days with the average trade being worth of $78,593. The most recent stock trade was executed by Richard Capasso on 15 August 2022, trading 1,183 units of SQZ stock currently worth $3,939.
What does SQZ Biotechnologies Co's logo look like?
Complete history of Holdings Temasek stock trades at Equinix Inc, Virtu Inc, CenturyLink oraz SQZ Biotechnologies Co
SQZ Biotechnologies Co executives and stock owners
SQZ Biotechnologies Co executives and other stock owners filed with the SEC include:
-
Dr. Armon R. Sharei Ph.D.,
Co-Founder, Pres, CEO, Interim Principal Financial Officer & Director -
Teri Loxam,
Consultant & Advisor -
Dr. Howard Bernstein M.D., Ph.D.,
Chief Scientific Officer -
Lawrence J. Knopf,
Gen. Counsel & Sec. -
Micah Zajic,
Chief Bus. Officer -
Ipsita Roymoulik Ph.D.,
Sr. VP of CMC & QUALITY -
Dr. Marshelle Smith Warren M.D.,
Chief Medical Officer -
David First,
Chief People Officer -
Dr. Howard Bernstein,
Chief Scientific Officer -
Richard V. Capasso CPA,
Chief Accounting Officer -
Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD,
Co-Founder & Member of Scientific Advisory Board -
Micah Zajic,
Chief Financial Officer -
Howard Phd Md Bernstein,
Interim Chief Executive Office -
Holdings (Private) Ltd Temasek,
10% owner -
Oliver Rosen,
Chief Medical Officer -
Paul Bolno,
Director -
Sapna Srivastava,
Director -
Teri Loxam,
Chief Financial Officer -
Pushkal Garg,
Director -
Klavs F. Jensen,
Director -
International Group, Inc. A...,
10% owner -
Marc Elia,
Director -
David First,
Chief People Officer -
Armon Sharei,
President and CEO -
Amy W Schulman,
Director -
Marc Schegerin,
Director -
Lawrence J Knopf,
General Counsel -
Eric Moessinger,
Director -
Schulman, As Trustee The Ar...,
10% owner -
Public Equities, L.P.Minne ...,
-
Management Co. Vii, L.L.C.P...,
-
Bernard Coulie,
Director -
Patrick V.J.J. Vink,
Director -
Richard Capasso,
See Remarks -
Marshelle Smith Warren,
Chief Medical Officer